Chemomab Therapeutics and AGC Biologics Expand Partnership to Manufacture CM-101 for Phase II/III Read more
Eisai And Biogen Inc. Announce U.S. FDA Grants Breakthrough Therapy Designation For Lecanemab (BAN2401) Read more
Koselugo approved in the EU for children with neurofibromatosis type 1 and plexiform neurofibromas Read more
CellPoint and Lonza Enter Strategic Collaboration to Deliver CAR-T Cells to Patients at Point-of-Care Read more
Amgen Announces Approval Of Aimovig (Erenumab) In Japan For The Suppression Of Onset Of Migraine Attacks In Adults Read more
AbCellera Continues Expansion and Strengthens Future Pandemic Preparedness with First-of- its-Kind GMP Manufacturing Facility for Therapeutic Antibodies in Canada Read more
European Commission Purchases Additional 150 Million Doses of Moderna’s COVID-19 Vaccine for Delivery in 2022 Read more
Eurofins Discovery and ImmunoPrecise Announce Collaboration to Expand their Antibody Discovery Platform Read more
Fujitsu Japan Embarks on Joint Research for COVID-19 Therapies Using World’s Fastest Supercomputer with Researchers of Research Center for Advanced Science and Technology, The University of Tokyo Read more
ViiV Healthcare and Halozyme enter global collaboration and license agreement for ENHANZE® drug delivery technology to enable development of “ultra-long-acting” medicines for HIV Read more